Kolexia
Etienne-Julan Maryse Médecine générale
Etienne-Julan Maryse
Médecine générale
Hôpital aux Abymes
Les Abymes, France
193 Activités
29 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose Anémie Hémolyse Drépanocytose SC Hémoglobinose C Syndrome thoracique aigu Alpha-Thalassémie Hypertension artérielle Maladies vasculaires

Collaborateurs

Voir plus
Lemonne Nathalie
Lemonne Nathalie
Centre Hospitalier de Antibes, Antibes, France
Divialle-Doumdo Lydia
Divialle-Doumdo Lydia
Hôpital aux Abymes, Les Abymes, France
Petras-Sophiyair Marie
Petras-Sophiyair Marie
Hôpital aux Abymes, Les Abymes, France
Lalanne-Mistrih Marie-Laure
Lalanne-Mistrih Marie-Laure
Hôpital aux Abymes, Les Abymes, France

Industries

Voir plus
Novartis
24 collaboration(s)
Dernière en 2023
GLOBAL BLOOD THERAPEUTICS FRANCE SAS
4 collaboration(s)
Dernière en 2023
Pfizer
4 collaboration(s)
Dernière en 2023
GSK
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.
American journal of hematology   22 janvier 2024
Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
Medicina (Kaunas, Lithuania)   18 décembre 2023
Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optimizing Albuminuria Assessment in Patients with Sickle Cell Disease: Insights from the Sikamic Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Double-Blind Randomized Study to Evaluate the Effect of Hydroxycarbamide on Albuminuria in Adults with Sickle Cell Disease: Sikamic (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Puberty Onset and Preservation of Fertility in Male Patients with Sickle Cell Disease Treated with Hydroxyurea: Data from the European Sickle Cell Disease Cohort - Hydroxyurea Extension (ESCORT-HU Extension) Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
SIKAMIC: Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Essai Clinique (Addmedica)   14 juin 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023
HDL2: Study of Lipid Balance in Adult Sickle Cell SS or SC Patients at Steady State and According to Clinical Phenotypes and During Acute Complications Acronym : "HDL2"
Essai Clinique (CHU Pointe à Pitre)   21 mars 2023
"Long-term efficacy and safety of L-glutamine in preventing sickle cell disease-related acute complications and hemolysis in pediatric and adult patients-Real-world, observational study".
European journal of haematology   20 février 2023